EUVIMEDEUVIMED entdecken
Crossref

Fostering Clinical Pharmacology and Drug Development in India: A Perspective From SAC‐ACCP

Karthik Venkatakrishnan, Abhigyan Ravula, Sagar Bachhav, Mohammad Faruq iD, Bratati Kahali, Avs Suresh, Sanish Davis iD, Manish Lavhale, Amruta Gadade, Gurusharan Dumra iD, Vikas Dighe, Vipin Dhote iD und 11 weitere

The Journal of Clinical Pharmacology · 2026-10 · 66 (10)

DOI: 10.1002/jcph.70307 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Pharmacology, online erschienen am 13.10.2026. Verfasst von Karthik Venkatakrishnan und 22 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Waltham, MA, USA. Hauptthemen laut MEDLINE: Pharmacology, Clinical, Drug Development. Die Arbeit nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since its inception in 2006, the South Asian College, Affiliate of the American College of Clinical Pharmacology (SAC‐ACCP), headquartered in Mumbai, India, has fostered the discipline, emphasizing education, training and dialogue across academia, regulators, and industry. The 2026 Annual Conference, themed “Think Global Act Local,” covered topics ranging from Artificial Intelligence in healthcare to the Genome India project and multi‑regional clinical trials, reflecting India's strategic maturation as it moves decisively from participation to co‐leadership in global drug development. This Commentary highlights the proceedings of this summit, celebrating India's emergence as a globally visible leader in biomedical research and drug development at a key milestone of the 20th Anniversary of SAC‐ACCP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pharmacology, ClinicalDrug DevelopmentIndiaHumansBiomedical Research

Autor:innen und Institutionen

  • Clinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Waltham, MA, USA.
  • Quantitative Pharmacology and Pharmacometrics, Merck & Co., Inc., Rahway, NJ, USA.
  • CSIR-Institute of Genomics and Integrative Biology, Delhi, India.
  • Centre for Brain Research, Indian Institute of Science, Bengaluru, India.
  • AOI Hospital, Hyderabad, India.
  • Clinical Sciences Oncology, Takeda Biopharmaceuticals India Pvt. Ltd., Mumbai, India.

ORCID-Profile: Mohammad Faruq, Sanish Davis, Gurusharan Dumra, Vipin Dhote, Bikash Medhi, Nirmala Rege, Taruna Madan, Ravi Shankar P Singh, Manoj Jadhav, Nilima Kshirsagar, Deven Parmar

Zitieren

APA

Venkatakrishnan, K., Ravula, A., Bachhav, S., Faruq, M., Kahali, B., Suresh, A., Davis, S., Lavhale, M., Gadade, A., Dumra, G., Dighe, V., Dhote, V., Medhi, B., Marthak, K., Rege, N., Garimella, T., Madan, T., Kota, J., Singh, R. S. P., …, & Parmar, D. (2026). Fostering Clinical Pharmacology and Drug Development in India: A Perspective From SAC‐ACCP. The Journal of Clinical Pharmacology, 66(10). https://doi.org/10.1002/jcph.70307

Vancouver

Venkatakrishnan K, Ravula A, Bachhav S, Faruq M, Kahali B, Suresh A, et al. Fostering Clinical Pharmacology and Drug Development in India: A Perspective From SAC‐ACCP. The Journal of Clinical Pharmacology. 2026;66(10). doi:10.1002/jcph.70307

BibTeX
@article{Venkatakrishnan2026,
  author = {Venkatakrishnan, Karthik and Ravula, Abhigyan and Bachhav, Sagar and Faruq, Mohammad and Kahali, Bratati and Suresh, Avs and Davis, Sanish and Lavhale, Manish and Gadade, Amruta and Dumra, Gurusharan and Dighe, Vikas and Dhote, Vipin and Medhi, Bikash and Marthak, Kiran and Rege, Nirmala and Garimella, Tushar and Madan, Taruna and Kota, Jagannath and Singh, Ravi Shankar P and Sunkara, Gangadhar and Jadhav, Manoj and Kshirsagar, Nilima and Parmar, Deven},
  title = {Fostering Clinical Pharmacology and Drug Development in India: A Perspective From SAC‐ACCP},
  journal = {The Journal of Clinical Pharmacology},
  year = {2026},
  volume = {66},
  number = {10},
  doi = {10.1002/jcph.70307}
}
Kostenlos starten →